Avita Medical

Closed portfolio snapshot

According to ClinicalTrials.gov-derived indexes, Avita Medical sits in the top decile of US sponsors by registered trial count (#1,049 of 15,742 sponsors by registered trial count).

13 total trials none currently recruiting 8 completed top decile by trial count

Avita Medical: 13 sponsored US clinical trials, none currently recruiting.

Avita Medical sponsors 13 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 8 completed. The most-studied condition in this pipeline is Trauma Wound, with 2 trials.

Top-decile sponsor footprint

Avita Medical ranks in the top decile of sponsors by registered trial count (#1,049 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

F 21/100

8 of 11 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (72.7%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Indexed trials (enrollment closed)

13 total, page 1 of 1

ACTIVE NOT RECRUITING NA

Multicenter Single-arm Trial to Investigate Clinical Outcomes When Cohealyx™ is Used for Full Thickness Wounds

NCT06787690

ACTIVE NOT RECRUITING NA

Randomized Controlled Trial to Investigate Clinical Outcomes and Associated Costs When PermeaDerm is Used as Temporary Dressing for Surgical Wounds

NCT06750809

COMPLETED NA

Repigmentation of Stable Vitiligo Lesions Using Spray-On Skin™ Cells

NCT05971381

TERMINATED NA

Feasibility Study to Evaluate RECELL and Melanocyte Keratinocyte Transplantation Procedure for Repigmentation of Stable Vitiligo Lesions

NCT04271501

COMPLETED NA

Clinical Study to Investigate the Safety and Effectiveness of RECELL for Repigmentation of Stable Vitiligo Lesions

NCT04547998

TERMINATED NA

RES® Prepared With RECELL® Compared to Standard of Care Dressings of Partial-thickness Burns in Ages 1-16 Years

NCT03626701

COMPLETED NA

RECELL® System Combined With Meshed Autograft for Reduction of Donor Skin Harvesting in Soft Tissue Reconstruction

NCT04091672

TERMINATED NA

RES Prepared With RECELL® Compared to Conventional Care for Healing of Donor Sites in Ages 1-16 Years

NCT03624192

COMPLETED

Continued Access to the Recell® Device for Treatment of Acute Burn Injuries

NCT03333941

COMPLETED NA

CONTINUED ACCESS PROTOCOL: Demonstration of the Safety and Effectiveness of ReCell® Combined With Meshed Skin Graft for Reduction of Donor Area in the Treatment of Acute Burn Injuries

NCT02994654

COMPLETED NA

ReCell® Combined With Meshed Skin Graft in the Treatment of Acute Burn Injuries

NCT02380612

COMPLETED

Prospective Evaluation of the ReCell® Autologous Cell Harvesting Device For Specific Compassionate Use Cases

NCT02992249

COMPLETED NA

A Multicenter Comparative Study of the ReCell Device and Autologous Split-thickness Meshed Skin Graft in the Treatment of Acute Burn Injuries

NCT01138917

How the Avita Medical archive is shaped

13 indexed studies, none listed as recruiting (0% open); 8 completed (62%).

Phase labels are sparse on this sponsor index, so phase mix is not charted here.

Top condition: Trauma Wound (2 trials), 8 others listed.

How to read a closed sponsor archive

When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.

Avita Medical: archived-pipeline peers nationwide

Peers matched on 13 indexed studies with no current recruiting: volume and archive shape, not condition overlap.

Avita Medical sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 051015 0%2%4%6%8%10% Total trials Recruiting share Avita MedicalAdaptimmuneAgennixAkili Interactive LabsAlumis10xBio22nd Century Group23andMe3-C Institute for Social Development
Avita Medical sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Avita Medical sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 13 archived trials

Sponsors with similar archive density (± trial count)

What to do with this Avita Medical page

13 registered trials is a research-attention snapshot, not an endorsement of Avita Medical or any single study.

  • None of Avita Medical's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
  • Trauma Wound is the condition Avita Medical studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Trauma Wound trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Avita Medical pipeline card: 13 registered trials from official public datasets.Report a data error.